A detailed history of Warren Averett Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 98,957 shares of ABBV stock, worth $17.7 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
98,957
Previous 100,882 1.91%
Holding current value
$17.7 Million
Previous $17.3 Million 12.94%
% of portfolio
0.37%
Previous 0.34%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $315,392 - $383,710
-1,925 Reduced 1.91%
98,957 $19.5 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $669,931 - $782,329
4,328 Added 4.48%
100,882 $17.3 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $10.3 Million - $11.8 Million
64,726 Added 203.36%
96,554 $17.6 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $315,104 - $354,881
2,290 Added 7.75%
31,828 $4.93 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $423,480 - $490,240
3,170 Added 12.02%
29,538 $4.4 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $395,807 - $492,556
2,987 Added 12.78%
26,368 $3.55 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $1.18 Million - $1.36 Million
-8,147 Reduced 25.84%
23,381 $3.73 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $394,183 - $472,729
2,850 Added 9.94%
31,528 $5.1 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $3.28 Million - $3.76 Million
24,414 Added 572.56%
28,678 $3.85 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $51,194 - $65,085
372 Added 9.56%
4,264 $653,000
Q1 2022

May 17, 2022

SELL
$131.98 - $163.75 $13,197 - $16,375
-100 Reduced 2.51%
3,892 $630,000
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $57,045 - $72,178
531 Added 15.34%
3,992 $567,000
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $76,592 - $85,328
728 Added 26.64%
3,461 $403,000
Q1 2021

May 24, 2021

BUY
$102.3 - $112.62 $56,878 - $62,616
556 Added 25.54%
2,733 $320,000
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $19,559 - $26,406
-243 Reduced 10.04%
2,177 $226,000
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $6,357 - $7,461
74 Added 3.15%
2,420 $206,000
Q2 2020

Aug 17, 2020

BUY
$73.37 - $98.18 $172,126 - $230,330
2,346 New
2,346 $222,000
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $153,510 - $232,740
-2,380 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$72.13 - $90.25 $171,669 - $214,795
2,380 New
2,380 $207,000
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $487,029 - $600,638
-6,256 Closed
0 $0
Q3 2018

Nov 05, 2018

SELL
$88.91 - $98.84 $4,623 - $5,139
-52 Reduced 0.82%
6,256 $592,000
Q2 2018

Aug 02, 2018

SELL
$89.78 - $106.23 $27,023 - $31,975
-301 Reduced 4.55%
6,308 $584,000
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $367,395 - $491,977
-3,993 Reduced 37.66%
6,609 $626,000
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $63,139 - $69,238
705 Added 7.12%
10,602 $1.03 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $691,305 - $883,010
9,897
9,897 $879,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Warren Averett Asset Management, LLC Portfolio

Follow Warren Averett Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warren Averett Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warren Averett Asset Management, LLC with notifications on news.